Short Interest in OSR Holdings, Inc. (NASDAQ:OSRH) Decreases By 37.6%

OSR Holdings, Inc. (NASDAQ:OSRH) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totaling 544,307 shares, a decrease of 37.6% from the December 15th total of 872,385 shares. Based on an average daily volume of 471,049 shares, the short-interest ratio is presently 1.2 days. Currently, 5.4% of the company’s stock are sold short. Currently, 5.4% of the company’s stock are sold short. Based on an average daily volume of 471,049 shares, the short-interest ratio is presently 1.2 days.

OSR Trading Down 4.4%

Shares of OSRH stock traded down $0.03 during trading hours on Friday, reaching $0.75. 1,252,668 shares of the company’s stock were exchanged, compared to its average volume of 2,787,571. The company has a market cap of $19.18 million, a price-to-earnings ratio of -0.67 and a beta of 1.42. OSR has a fifty-two week low of $0.45 and a fifty-two week high of $12.54. The stock’s 50 day moving average is $0.63 and its 200-day moving average is $0.71.

OSR (NASDAQ:OSRH) last announced its earnings results on Wednesday, November 12th. The company reported ($0.10) earnings per share for the quarter. The company had revenue of $0.63 million during the quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on OSRH shares. Weiss Ratings reissued a “sell (e+)” rating on shares of OSR in a research note on Monday, December 29th. Wall Street Zen raised OSR to a “sell” rating in a research report on Saturday, October 18th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, OSR has an average rating of “Sell”.

Hedge Funds Weigh In On OSR

An institutional investor recently bought a new position in OSR stock. Susquehanna International Group LLP bought a new position in shares of OSR Holdings, Inc. (NASDAQ:OSRH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 79,807 shares of the company’s stock, valued at approximately $43,000. Susquehanna International Group LLP owned about 0.37% of OSR at the end of the most recent quarter. Hedge funds and other institutional investors own 55.30% of the company’s stock.

About OSR

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials.